Intrathecal Additives for Spinal Anaesthesia in Elective Caesarean Sections

• Status: Not yet recruiting
• Trial end date: 2021-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

we designed this randomized, single -blind, prospective clinical study to test postoperative analgesia of three intrathecal additives in elective caesarean sections which are magnesium, dexamethasone and dexmedetomidine.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Benha University
• Treatments: Dexmedetomidine

Criteria

Inclusion Criteria:

• American Society of Anesthesiologists classII-III adult female patient (age :18 -40 years old )

• Elective cesarean section under spinal anaesthesia

• Gestational age > 37 weeks

• BMI less than 30 kg/m2

Exclusion Criteria:

• Patient refusal

• unable to give consent

• age < 18 or > 40

• BMI more than 30 kg/m2

• known allergy to the study medication

• coagulopathies or on anticoagulant medications

• diabetic neuropathy

• patients with psychiatric disorders